Analyst Ratings For Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Today, Maxim Group initiated coverage on Adial Pharmaceuticals Inc (NASDAQ:ADIL) with a Buy with a price target of $5.00.
There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Adial Pharmaceuticals Inc (NASDAQ:ADIL) is Buy with a consensus target price of $5.00 per share, a potential 157.61% upside.
Some recent analyst ratings include
- 10/30/2018-Adial Pharmaceuticals Inc (NASDAQ:ADIL) has coverage initiated with a Buy ➝ Buy rating and $5.00 price target
- 10/11/2018-Adial Pharmaceuticals Inc (NASDAQ:ADIL) has coverage initiated with a Buy rating
Recent Trading Activity for Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Shares of Adial Pharmaceuticals Inc closed the previous trading session at 1.94 up +0.061 3.24% with 2.01 shares trading hands.